ArticlePediatric rheumatology online journal2026
Natural killer cells as biomarkers for disease activity, lupus nephritis, and time to remission in treatment-naïve childhood-onset systemic lupus erythematosus: a cohort study.
Article in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesAdaptive immunity is well-established in lupus pathogenesis, yet the clinical significance of innate immune components, particularly natural killer (NK) cells, remains underexplored. This study aims to evaluate the clinical relevance of NK cell levels in treatment-naïve, infection-free patients with childhood-onset systemic lupus erythematosus (cSLE).
methodsWe conducted a retrospective cohort study among 96 treatment-naïve, infection-free cSLE patients diagnosed during 2015–2025. Logistic regression was applied to compare patients of moderate-to-severe disease activity (SLEDAI > 9) versus low disease activity (SLEDAI ≤ 9), and to assess the associations between NK cell levels and organ involvement. Cox regression analysis was performed to evaluate the effect of baseline NK cell counts on the time to first remission. To evaluate whether longitudinal changes in absolute NK cell counts are associated with the timing of initial remission, we performed a linear mixed-effects model analysis in the subset of patients with serial NK cell data.
resultsBoth absolute NK cell counts and percentages were lower than healthy references. Anti-dsDNA positivity (OR = 5.107, 95% CI: 1.257–20.757, P = 0.023), neuropsychiatric involvement (OR = 33.306, 95% CI: 6.79–163.32, P < 0.001), and absolute NK cell count (OR = 0.982, 95% CI: 0.969–0.995, P = 0.007) were independent factors associated with higher disease activity. Similarly, independent factors for lupus nephritis included anti-dsDNA positivity (OR = 8.555, 95% CI: 2.302–31.791, P = 0.001) and absolute NK cell count (OR = 0.991, 95% CI: 0.982–1.000, P = 0.041). During follow-up, in multivariate Cox regression with forward likelihood ratio, higher absolute NK cell count was independently associated with a shorter time to first remission (HR 1.005, 95% CI 1.001–1.009, P = 0.015), whereas hypocomplementemia was independently associated with a longer time to first remission (HR 0.472, 95% CI 0.244–0.912, P = 0.026). The optimal cut-off was 126 cells/µL.
conclusionsAbsolute NK cell count is a clinically relevant biomarker in cSLE. Compared with healthy controls, cSLE exhibit consistently reduced NK cell count and percentage across all age groups. Absolute NK cell count independently stratifies patients with cSLE by disease activity, clinical diagnosis of lupus nephritis, and time to first remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.